The San Diego company says its blood test can detect pancreatic cancer when curative surgery may still be an option.

ClearNote Health secures $52 million to scale early cancer detection and expand global clinical and commercial operations.

Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision ...

Proceeds will support continued commercial expansion, operational scale-up, clinical study execution, and product development * Clinical oncology ...

SINGAPORE, May 28, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S.

Researchers have identified a distinct saliva microbiome signature linked to esophageal cancer, raising the possibility of a ...

Pancreatic cancer remains one of the deadliest malignancies, due in large part to challenges with early diagnosis.  Advanced pancreatic cancer diagnos | Cancer ...

MENLO PARK, Calif., May 26, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management ...

A new endomicroscope combines AI-designed optics and deep learning to provide high-resolution cancer imaging across larger ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today ...